186 related articles for article (PubMed ID: 25339775)
1. Persistent hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1.
Panigrahi R; Chandra PK; Ferraris P; Kurt R; Song K; Garry RF; Reiss K; Coe IR; Furihata T; Balart LA; Wu T; Dash S
J Virol; 2015 Jan; 89(1):626-42. PubMed ID: 25339775
[TBL] [Abstract][Full Text] [Related]
2. HCV infection selectively impairs type I but not type III IFN signaling.
Chandra PK; Bao L; Song K; Aboulnasr FM; Baker DP; Shores N; Wimley WC; Liu S; Hagedorn CH; Fuchs SY; Wu T; Balart LA; Dash S
Am J Pathol; 2014 Jan; 184(1):214-29. PubMed ID: 24215913
[TBL] [Abstract][Full Text] [Related]
3. ENT1, a ribavirin transporter, plays a pivotal role in antiviral efficacy of ribavirin in a hepatitis C virus replication cell system.
Iikura M; Furihata T; Mizuguchi M; Nagai M; Ikeda M; Kato N; Tsubota A; Chiba K
Antimicrob Agents Chemother; 2012 Mar; 56(3):1407-13. PubMed ID: 22232287
[TBL] [Abstract][Full Text] [Related]
4. Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis.
Chandra PK; Gunduz F; Hazari S; Kurt R; Panigrahi R; Poat B; Bruce D; Cohen AJ; Bohorquez HE; Carmody I; Loss G; Balart LA; Wu T; Dash S
PLoS One; 2014; 9(9):e108616. PubMed ID: 25265476
[TBL] [Abstract][Full Text] [Related]
5. Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance.
Ibarra KD; Pfeiffer JK
J Virol; 2009 May; 83(9):4538-47. PubMed ID: 19244331
[TBL] [Abstract][Full Text] [Related]
6. Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation.
Panigrahi R; Hazari S; Chandra S; Chandra PK; Datta S; Kurt R; Cameron CE; Huang Z; Zhang H; Garry RF; Balart LA; Dash S
PLoS One; 2013; 8(8):e72791. PubMed ID: 24009705
[TBL] [Abstract][Full Text] [Related]
7. Host-based ribavirin resistance influences hepatitis C virus replication and treatment response.
Ibarra KD; Jain MK; Pfeiffer JK
J Virol; 2011 Jul; 85(14):7273-83. PubMed ID: 21543469
[TBL] [Abstract][Full Text] [Related]
8. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
Kurt R; Chandra PK; Aboulnasr F; Panigrahi R; Ferraris P; Aydin Y; Reiss K; Wu T; Balart LA; Dash S
PLoS One; 2015; 10(5):e0125962. PubMed ID: 25961570
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556
[TBL] [Abstract][Full Text] [Related]
10. Equilibrative nucleoside transporter 1 expression in primary human hepatocytes is highly variable and determines uptake of ribavirin.
Baloch K; Chen L; Memon AA; Dexter L; Irving W; Ilyas M; Thomson BJ
Antivir Chem Chemother; 2017 Apr; 25(1):2-10. PubMed ID: 28417642
[TBL] [Abstract][Full Text] [Related]
11. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
[TBL] [Abstract][Full Text] [Related]
12. Contribution of CNT1 and ENT1 to ribavirin uptake in human hepatocytes.
Choi MK; Kim MH; Maeng HJ; Song IS
Arch Pharm Res; 2015; 38(5):904-13. PubMed ID: 25011570
[TBL] [Abstract][Full Text] [Related]
13. Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes.
Testoni B; Durantel D; Lebossé F; Fresquet J; Helle F; Negro F; Donato MF; Levrero M; Zoulim F
Gut; 2016 Apr; 65(4):672-82. PubMed ID: 26082258
[TBL] [Abstract][Full Text] [Related]
14. Ribavirin induced hemolysis: a novel mechanism of action against chronic hepatitis C virus infection.
Soota K; Maliakkal B
World J Gastroenterol; 2014 Nov; 20(43):16184-90. PubMed ID: 25473172
[TBL] [Abstract][Full Text] [Related]
15. ENT1 and treatment of viral diseases.
Panigrahi R; Dash S
Oncotarget; 2015 Oct; 6(32):32281-2. PubMed ID: 26431496
[No Abstract] [Full Text] [Related]
16. Influence of a single nucleotide polymorphism at the main ribavirin transporter gene on the rapid virological response to pegylated interferon-ribavirin therapy in patients with chronic hepatitis C virus infection.
Morello J; Cuenca L; Soriano V; Medrano J; Madejón A; Vispo E; Barreiro P; Labarga P; Jiménez-Nácher I; Rodríguez-Nóvoa S
J Infect Dis; 2010 Oct; 202(8):1185-91. PubMed ID: 20812847
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of autophagy-related gene ATG5 and GABARAP expression by IFN-λ1 contributes to its anti-HCV activity in human hepatoma cells.
Li X; Li Y; Fang S; Su J; Jiang J; Liang B; Huang J; Zhou B; Zang N; Ho W; Li J; Li Y; Chen H; Ye L; Liang H
Antiviral Res; 2017 Apr; 140():83-94. PubMed ID: 28131804
[TBL] [Abstract][Full Text] [Related]
18. Establishment of hepatitis C virus RNA-replicating cell lines possessing ribavirin-resistant phenotype.
Satoh S; Mori K; Ueda Y; Sejima H; Dansako H; Ikeda M; Kato N
PLoS One; 2015; 10(2):e0118313. PubMed ID: 25699517
[TBL] [Abstract][Full Text] [Related]
19. The role of the equilibrative nucleoside transporter 1 on tissue and fetal distribution of ribavirin in the mouse.
Endres CJ; Moss AM; Ishida K; Govindarajan R; Unadkat JD
Biopharm Drug Dispos; 2016 Sep; 37(6):336-44. PubMed ID: 27194214
[TBL] [Abstract][Full Text] [Related]
20. Ribavirin regulates hepatitis C virus replication through enhancing interferon-stimulated genes and interleukin 8.
Tokumoto Y; Hiasa Y; Uesugi K; Watanabe T; Mashiba T; Abe M; Kumagi T; Ikeda Y; Matsuura B; Onji M
J Infect Dis; 2012 Apr; 205(7):1121-30. PubMed ID: 22357660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
